DCM
TARS icon

Driehaus Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Driehaus Capital Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20M Sell
317,576
-608,549
-66% -$38.9M 0.12% 231
2026
Q1 		$65M Sell
926,125
-246,302
-21% -$17.2M 0.48% 61
2025
Q4 		$96M Buy
1,172,427
+141,386
+14% +$10.6M 0.65% 36
2025
Q3 		$61.3M Buy
1,031,041
+154,494
+18% +$7.61M 0.44% 71
2025
Q2 		$35.5M Buy
876,547
+158,694
+22% +$7.14M 0.28% 116
2025
Q1 		$36.9M Buy
+717,853
New +$35.5M 0.36% 89
2024
Q3 		– Sell
-364,463
Closed -$9.91M – 450
2024
Q2 		$9.91M Buy
364,463
+203,300
+126% +$6.84M 0.1% 217
2024
Q1 		$5.86M Buy
+161,163
New +$4.74M 0.06% 274

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Driehaus Capital Management's TARS Position: Q2 2026 in Review

Driehaus Capital Management reduced its Tarsus Pharmaceuticals (TARS) stake by 66% in Q2 2026, selling an estimated $38.9M and leaving 317,576 shares worth $20M. The position accounts for 0.12% of the portfolio, ranked #231.

Driehaus Capital Management first reported a position in TARS in Q1 2024 and has held it in 8 quarters since. The position peaked at $96M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Driehaus Capital Management held 317,576 shares of Tarsus Pharmaceuticals worth $20M as of Q2 2026.
  • Driehaus Capital Management sold 608,549 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $38.9M.
  • Tarsus Pharmaceuticals made up 0.12% of Driehaus Capital Management's portfolio in Q2 2026, its #231 holding.
  • Driehaus Capital Management first reported a position in Tarsus Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
  • Driehaus Capital Management's Tarsus Pharmaceuticals position peaked at $96M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.